Title : Vandetanib for the treatment of thyroid cancer: an update.

Pub. Date : 2014 Mar

PMID : 24502390






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 EXPERT OPINION: Vandetanib targets multiple cell-signaling pathways involved in the molecular pathogenesis of thyroid cancer, namely vascular endothelial growth factor receptor-2, epidermal growth factor receptor and rearranged during transfection receptor. vandetanib kinase insert domain receptor Homo sapiens